Escalating Myoclonus and Delirium on Morphine in Advanced Kidney Disease
Mrs. R is a 72-year-old retired teacher with metastatic pancreatic cancer and a solitary kidney (eGFR 22 mL/min/1.73 m²). For three weeks she has taken morphine extended-release 30 mg orally every 12 hours plus immediate-release morphine 10 mg every 4 hours as needed, averaging five rescue doses daily. Her daughter reports two days of coarse arm jerking, vivid dreams, and new confusion. Today Mrs. R is drowsy but rousable, with a Richmond Agitation-Sedation Scale score of −1. She rates upper abdominal and mid-back pain at 7/10, deep and constant, with a superimposed burning band across the upper abdomen. She is afebrile, postural blood pressure is stable, and a bladder scan shows 120 mL. She takes ondansetron and nothing else sedating.
1. Calculate her current total daily morphine dose and explain why this regimen is problematic. Propose a specific opioid rotation, including dose reduction and monitoring.
Read the worked answer
Total daily dose: extended-release 30 mg × 2 = 60 mg, plus roughly 5 × 10 mg rescue = 50 mg, so about 110 mg of oral morphine per day.
Why it is the wrong drug here: morphine is cleared renally, and its metabolites (morphine-6-glucuronide and morphine-3-glucuronide) accumulate at an eGFR of 22. The resulting syndrome is myoclonus, sedation, vivid dreams, and delirium that can be mistaken for uncontrolled pain or 'tolerance.' Adding more morphine makes it worse.
Rotation: oral morphine to oral hydromorphone is roughly 5:1, so 110 mg/day equates to about 22 mg/day. Reduce by 25–50% for incomplete cross-tolerance plus renal impairment, giving roughly 11–16 mg/day: for example, hydromorphone 1 mg orally every 4 hours scheduled with 0.5 mg every 2 hours as needed, titrated to effect. Fentanyl has no active metabolites and is the safest choice kinetically; transdermal fentanyl 12–25 mcg/h is a cautious starting point but is unsuitable for rapid titration. Stop morphine now rather than layering a rescue dose on top, reassess pain and sedation every 24 hours, and prescribe bowel prophylaxis.
2. What is your differential for the new myoclonus and confusion, and what immediate evaluation and treatment would you order?
Read the worked answer
The leading diagnosis is opioid neurotoxicity from accumulated morphine metabolites, but do not stop there.
- Metabolic: hypercalcemia (common in pancreatic and bone-metastatic disease), hyponatremia, hyperglycemia, uremia, dehydration.
- Infection: urinary tract infection, aspiration pneumonia, cholangitis; she is afebrile but older adults often are.
- Structural: brain metastases or a new bleed, especially if there are focal findings or headache.
- Drugs and other: ondansetron, anticholinergics, urinary retention (120 mL is not retention), constipation, pain itself.
Order calcium, comprehensive metabolic panel, glucose, urinalysis, and imaging if focal signs. Stop the morphine and rotate as above. Treat delirium nonpharmacologically first (orientation, glasses, hearing aids, sleep hygiene) and use haloperidol 0.5 mg orally or intravenously every 8 hours as needed for agitation, with caution about QT prolongation. For persistent myoclonus, low-dose clonazepam 0.25–0.5 mg or midazolam can help, but avoid benzodiazepines as a primary treatment for delirium. Reassess within hours, not days.
3. How would you treat the burning abdominal band, including drug selection and renal dose adjustment?
Read the worked answer
The burning, band-like quality suggests a neuropathic component, likely from celiac plexus or splanchnic nerve involvement by the pancreatic tumor. Treat it as an adjuvant problem rather than escalating the opioid alone.
- Gabapentin: start 100–300 mg at bedtime for eGFR 15–29, titrate slowly to a maximum of about 200–300 mg twice daily; watch for sedation, which compounds opioid effects.
- Pregabalin: 25–50 mg daily, similarly renally adjusted, is an alternative.
- Topical lidocaine 5% patch over the painful dermatome is a reasonable low-risk adjunct.
- Avoid codeine and tramadol (prodrugs and seizure risk), and avoid duloxetine in severe renal impairment.
- Consider methadone as a second-line agent for neuropathic cancer pain because it has no active renally cleared metabolites; obtain an ECG for QT and use only with experienced support.
- Consider referral for a neurolytic celiac plexus block, which has good evidence for upper abdominal pancreatic pain and can substantially reduce opioid needs.
Reassess in 3–5 days; gabapentinoids take time and cause drowsiness, so document the titration plan and follow-up.